Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, August 07, 2012

Oxigene Announces Phase 2 Ovarian Cancer Trial of Zybrestat Plus Bevacizumab Achieves Important Interim Safety Objective

http://pharmalive.com/News/Index.cfm?articleid=851802

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.